Coherus Biosciences, Inc. (CHRS) released Loss for fourth quarter of -$50.7 million
The company's earnings came in at -$50.7 million, or -$0.44 per share. This compares with -$79.7 million, or -$0.71 per share, last year.
Excluding items, Coherus Biosciences, Inc. reported adjusted earnings of -$32.5 million or -$0.28 per share for the period.
The company's revenue for the period fell 40.8% to $54.14 million from $91.52 million last year.
Coherus Biosciences, Inc. earnings at a glance (GAAP) :
-Earnings: -$50.7 Mln. vs. -$79.7 Mln. last year.
-EPS: -$0.44 vs. -$0.71 last year.
-Revenue: $54.14 Mln vs. $91.52 Mln last year.
For comments and feedback: editorial@rttnews.com